Matches in SemOpenAlex for { <https://semopenalex.org/work/W2334334012> ?p ?o ?g. }
Showing items 1 to 77 of
77
with 100 items per page.
- W2334334012 endingPage "PL01.001" @default.
- W2334334012 startingPage "PL01.001" @default.
- W2334334012 abstract "Objective: To provide the clinical features and suggest treatment guidelines for anti-NMDA-receptor encephalitis. Background Anti-NMDA-receptor encephalitis is the most common and best characterized antibody-mediated encephalitis. We provide the clinical features, treatment, and follow-up of 500 patients. Design/Methods: Cohort study, analysis of demographics, onset, treatment, and long-term follow-up. Results: 82% were female. Median age was 21 years (range 1-85; 36% 45 years). 42% had a tumor (95% teratomas). 55% of females >12 years had ovarian teratoma(s) versus 8% 3 of the following: psychiatric symptoms, memory, speech disorders, seizures, dyskinesias, decreased level of consciousness, autonomic instability, or hypoventilation. Within the first month, movement disorders and ataxia were more frequent in children (92% and 17% vs 70% and 2%, p Conclusions: Anti-NMDA-receptor encephalitis is a severe but treatable disorder of predominantly young individuals. Prompt treatment improves outcome. If initial immunotherapy fails, second-line treatment is usually effective. 75% of patients have full/substantial improvement although the process of recovery can take >24 months. Supported by: In part by grants from the National Institutes of Health and National Cancer Institute RO1CA89054 (Dalmau), 1RC1NS068204-01 (Balice-Gordon and Dalmau), a McKnight Neuroscience of Brain Disorders award (Balice-Gordon and Dalmau), a KWF fellowship 2009-4451 of the Dutch Cancer Society (Titulaer), and a grant from the Fondo de Investigaciones Sanitarias, FIS, Spain (Martinez-Hernandez). Disclosure: Dr. Titulaer has nothing to disclose. Dr. McCracken has nothing to disclose. Dr. Gabilondo Cuellar has nothing to disclose. Dr. Martinez-Hernandez has nothing to disclose. Dr. Graus has nothing to disclose. Dr. Balice-Gordon has nothing to disclose. Dr. Dalmau has received personal compensation in an editorial capacity for Up To Date, Inc.Dr. Dalmau has received research support from Euroimmun." @default.
- W2334334012 created "2016-06-24" @default.
- W2334334012 creator A5000213801 @default.
- W2334334012 creator A5034149246 @default.
- W2334334012 creator A5040779311 @default.
- W2334334012 creator A5055148980 @default.
- W2334334012 creator A5055333491 @default.
- W2334334012 creator A5063251362 @default.
- W2334334012 creator A5081544542 @default.
- W2334334012 date "2012-04-22" @default.
- W2334334012 modified "2023-09-27" @default.
- W2334334012 title "Clinical Features, Treatment, and Outcome of 500 Patients with Anti-NMDA Receptor Encephalitis (PL01.001)" @default.
- W2334334012 doi "https://doi.org/10.1212/wnl.78.1_meetingabstracts.pl01.001" @default.
- W2334334012 hasPublicationYear "2012" @default.
- W2334334012 type Work @default.
- W2334334012 sameAs 2334334012 @default.
- W2334334012 citedByCount "16" @default.
- W2334334012 countsByYear W23343340122012 @default.
- W2334334012 countsByYear W23343340122013 @default.
- W2334334012 countsByYear W23343340122016 @default.
- W2334334012 countsByYear W23343340122017 @default.
- W2334334012 countsByYear W23343340122018 @default.
- W2334334012 countsByYear W23343340122019 @default.
- W2334334012 countsByYear W23343340122021 @default.
- W2334334012 countsByYear W23343340122022 @default.
- W2334334012 countsByYear W23343340122023 @default.
- W2334334012 crossrefType "journal-article" @default.
- W2334334012 hasAuthorship W2334334012A5000213801 @default.
- W2334334012 hasAuthorship W2334334012A5034149246 @default.
- W2334334012 hasAuthorship W2334334012A5040779311 @default.
- W2334334012 hasAuthorship W2334334012A5055148980 @default.
- W2334334012 hasAuthorship W2334334012A5055333491 @default.
- W2334334012 hasAuthorship W2334334012A5063251362 @default.
- W2334334012 hasAuthorship W2334334012A5081544542 @default.
- W2334334012 hasConcept C126322002 @default.
- W2334334012 hasConcept C144237770 @default.
- W2334334012 hasConcept C148220186 @default.
- W2334334012 hasConcept C159047783 @default.
- W2334334012 hasConcept C170493617 @default.
- W2334334012 hasConcept C2522874641 @default.
- W2334334012 hasConcept C2780211071 @default.
- W2334334012 hasConcept C33923547 @default.
- W2334334012 hasConcept C67018056 @default.
- W2334334012 hasConcept C71924100 @default.
- W2334334012 hasConcept C83455156 @default.
- W2334334012 hasConceptScore W2334334012C126322002 @default.
- W2334334012 hasConceptScore W2334334012C144237770 @default.
- W2334334012 hasConceptScore W2334334012C148220186 @default.
- W2334334012 hasConceptScore W2334334012C159047783 @default.
- W2334334012 hasConceptScore W2334334012C170493617 @default.
- W2334334012 hasConceptScore W2334334012C2522874641 @default.
- W2334334012 hasConceptScore W2334334012C2780211071 @default.
- W2334334012 hasConceptScore W2334334012C33923547 @default.
- W2334334012 hasConceptScore W2334334012C67018056 @default.
- W2334334012 hasConceptScore W2334334012C71924100 @default.
- W2334334012 hasConceptScore W2334334012C83455156 @default.
- W2334334012 hasIssue "Meeting Abstracts 1" @default.
- W2334334012 hasLocation W23343340121 @default.
- W2334334012 hasOpenAccess W2334334012 @default.
- W2334334012 hasPrimaryLocation W23343340121 @default.
- W2334334012 hasRelatedWork W2044141036 @default.
- W2334334012 hasRelatedWork W2068226440 @default.
- W2334334012 hasRelatedWork W2073155898 @default.
- W2334334012 hasRelatedWork W2183171754 @default.
- W2334334012 hasRelatedWork W2188633644 @default.
- W2334334012 hasRelatedWork W2194127728 @default.
- W2334334012 hasRelatedWork W2396909349 @default.
- W2334334012 hasRelatedWork W2407635011 @default.
- W2334334012 hasRelatedWork W2418328013 @default.
- W2334334012 hasRelatedWork W2545858212 @default.
- W2334334012 hasVolume "78" @default.
- W2334334012 isParatext "false" @default.
- W2334334012 isRetracted "false" @default.
- W2334334012 magId "2334334012" @default.
- W2334334012 workType "article" @default.